Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Annals of Neurology
|
July 26, 2016
Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination
Yi Shiau Ng, Catherine Feeney, Andrew M Schaefer, et al.
British Journal of Cancer
|
June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations
Subotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Annals of Neurology
|
December 29, 2017
Pathological mechanisms underlying single large-scale mitochondrial DNA deletions
Mariana C Rocha, Hannah S Rosa, John P Grady, et al.
EMBO Molecular Medicine
|
May 9, 2018
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
John P Grady, Sarah J Pickett, Yi Shiau Ng, et al.
European Heart Journal
|
July 19, 2015
Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults
Yi Shiau Ng, John P Grady, Nichola Z Lax, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2020
Molecular patterns in salivary duct carcinoma identify prognostic subgroups
Simon A Mueller, Marie-Emilie A Gauthier, James Blackburn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
NPJ Precision Oncology
|
September 9, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
Subotheni Thavaneswaran, Frank Lin, John P Grady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Scientific Reports
|
November 21, 2019
Development and validation of a targeted gene sequencing panel for application to disparate cancers
Mark J McCabe, Marie-Emilie A Gauthier, Chia-Ling Chan, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Annals of Neurology
|
July 26, 2016
Pseudo-obstruction, stroke, and mitochondrial dysfunction: A lethal combination
Yi Shiau Ng, Catherine Feeney, Andrew M Schaefer, et al.
British Journal of Cancer
|
June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterations
Subotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Annals of Neurology
|
December 29, 2017
Pathological mechanisms underlying single large-scale mitochondrial DNA deletions
Mariana C Rocha, Hannah S Rosa, John P Grady, et al.
EMBO Molecular Medicine
|
May 9, 2018
mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease
John P Grady, Sarah J Pickett, Yi Shiau Ng, et al.
European Heart Journal
|
July 19, 2015
Sudden adult death syndrome in m.3243A>G-related mitochondrial disease: an unrecognized clinical entity in young, asymptomatic adults
Yi Shiau Ng, John P Grady, Nichola Z Lax, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
May 28, 2020
Molecular patterns in salivary duct carcinoma identify prognostic subgroups
Simon A Mueller, Marie-Emilie A Gauthier, James Blackburn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
NPJ Precision Oncology
|
September 9, 2024
A signal-seeking phase 2 study of Trastuzumab emtansine in tumours harbouring HER2 amplification or mutation
Subotheni Thavaneswaran, Frank Lin, John P Grady, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Scientific Reports
|
November 21, 2019
Development and validation of a targeted gene sequencing panel for application to disparate cancers
Mark J McCabe, Marie-Emilie A Gauthier, Chia-Ling Chan, et al.
Page
of 5